dc.contributor.author | Kan, Emrah | |
dc.contributor.author | Kan, Elif K. | |
dc.contributor.author | Okuyucu, Ali | |
dc.date.accessioned | 2020-06-21T13:18:24Z | |
dc.date.available | 2020-06-21T13:18:24Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 1120-6721 | |
dc.identifier.issn | 1724-6016 | |
dc.identifier.uri | https://doi.org/10.5301/ejo.5000932 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/12265 | |
dc.description | WOS: 000415309800007 | en_US |
dc.description | PubMed: 28127733 | en_US |
dc.description.abstract | Purpose: To compare the central corneal thickness (CCT), intraocular pressure (IOP), and tear insulin-like growth factor 1 (IGF-1) levels between patients with acromegaly and a control group and to evaluate the possible effect of tear IGF-1 and duration of the disease on CCT and IOP. Methods: We included 31 patients with acromegaly (study group) and 40 age- and sex-matched controls in the study. Patients with acromegaly were divided into 2 subgroups based on disease status (active/inactive). All participants underwent complete ophthalmologic evaluation including CCT and IOP values. Basal tear samples were collected from both groups and tear IGF-1 levels were measured. The CCT, IOP, and tear IGF-1 levels were compared between groups and subgroups and the association between tear IGF-I levels and ocular parameters (CCT, IOP) and disease duration were also evaluated. Results: Central corneal thickness, IOP, and tear IGF-1 levels did not show a significant difference between study and control groups. We also did not find a significant difference in terms of CCT, IOP, or tear IGF-1 levels between subgroups of patients. Correlation analysis did not show an association between the duration of disease and tear IGF-1 levels with CCT or IOP. Conclusions: There was no significant difference in tear IGF-1 levels between patients with acromegaly and controls. Additionally, there was no correlation between disease duration and tear IGF-1 levels with CCT or IOP levels. This lack of association may suggest that tear IGF-1 levels might not have an effect on CCT or IOP findings in patients with acromegaly. | en_US |
dc.description.sponsorship | Samsun Training and Research Hospital Research Board | en_US |
dc.description.sponsorship | Partial support for this work was provided by Samsun Training and Research Hospital Research Board. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Wichtig Publishing | en_US |
dc.relation.isversionof | 10.5301/ejo.5000932 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Acromegaly | en_US |
dc.subject | Central corneal thickness | en_US |
dc.subject | Insulin-like growth factor | en_US |
dc.subject | Intraocular pressure | en_US |
dc.subject | Tear collection | en_US |
dc.title | The evaluation of central corneal thickness and intraocular pressure in conjunction with tear IGF-1 levels in patients with acromegaly | en_US |
dc.type | article | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 27 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 531 | en_US |
dc.identifier.endpage | 534 | en_US |
dc.relation.journal | European Journal of Ophthalmology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |